Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Dyscrasias”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT00048412
What this trial is testing

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Who this might be right for
Myelodysplastic DisordersLeukemiaMultiple Myeloma+2 more
Baylor College of Medicine 40
Not applicableStudy completedNCT02274519
What this trial is testing

Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Disorder
Mayo Clinic 29
Not applicableLooking for participantsNCT03616483
What this trial is testing

The Indiana Myeloma Registry

Who this might be right for
Plasma Cell Dyscrasias
Indiana University 2,500
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT01816620
What this trial is testing

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Who this might be right for
POEMS Syndrome
Peking Union Medical College Hospital 41
Not applicableNot Yet RecruitingNCT06286215
What this trial is testing

Registry of Patients With Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorders
Siriraj Hospital 750
Not applicableLooking for participantsNCT01351545
What this trial is testing

Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Who this might be right for
Hematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets+14 more
Center for International Blood and Marrow Transplant Research 99,999
Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Testing effectiveness (Phase 2)Ended earlyNCT00579111
What this trial is testing

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Who this might be right for
Myelodysplastic and Myeloproliferative DisordersAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Baylor College of Medicine 4
Large-scale testing (Phase 3)Active Not RecruitingNCT04512235
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 281
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableLooking for participantsNCT01408225
What this trial is testing

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

Who this might be right for
Plasma Cell DyscrasiasMonoclonal Gammopathy of Undetermined SignificanceAL Amyloidosis+1 more
Ohio State University Comprehensive Cancer Center 5,000
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Not applicableWithdrawnNCT05362331
What this trial is testing

Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
LymphomaLeukemiaPlasma Cell Dyscrasia
University of California, San Francisco
Testing effectiveness (Phase 2)Looking for participantsNCT07075510
What this trial is testing

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorder
University of Maryland, Baltimore 30
Not applicableStudy completedNCT01186224
What this trial is testing

Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)

Who this might be right for
Multiple MyelomaPlasma Cell DyscrasiaLymphoma+1 more
University of Liverpool 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03480360
What this trial is testing

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Dartmouth-Hitchcock Medical Center 21
Not applicableLooking for participantsNCT06760052
What this trial is testing

Longitudinal Data Registry of Plasma Cell Dyscrasia

Who this might be right for
Multiple Myeloma and Other Plasma Cell Neoplasms
Shanghai Zhongshan Hospital 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT04879043
What this trial is testing

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Disorder
Heidelberg Pharma AG 78
Not applicableNot Yet RecruitingNCT06330896
What this trial is testing

Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing

Who this might be right for
Plasma Cell Disorder
Siriraj Hospital 498
Load More Results